BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4353168)

  • 1. Studies on the possible role of cyclic AMP in drug-induced coronary vasodilatation.
    Pöch G; Kukovetz WR
    Adv Cyclic Nucleotide Res; 1972; 1():195-211. PubMed ID: 4353168
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phosphodiesterase inhibition as the action mechanism of various coronary vasodilator agents].
    Kukovetz WR; Pöch G; Holzmann S
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):730. PubMed ID: 4341664
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of cyclic-3',5'-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs.
    Kukovetz WR; Pöch G
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 267(2):189-94. PubMed ID: 4320455
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation of the effects of sodium nitroprusside and of isoproterenol by selective phosphodiesterase inhibitors.
    Lorenz KL; Wells JN
    Mol Pharmacol; 1983 Mar; 23(2):424-30. PubMed ID: 6300651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.
    Sakamoto N; Terai M; Takenaka T; Maeno H
    Biochem Pharmacol; 1978; 27(8):1269-74. PubMed ID: 81059
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphodiesterases from porcine coronary arteries: inhibition of separated forms by xanthines, papaverine, and cyclic nucleotides.
    Wells JN; Wu YJ; Baird CE; Hardman JG
    Mol Pharmacol; 1975 Nov; 11(6):775-83. PubMed ID: 173982
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of papaverine derivatives on cyclic 3',5'-AMP phosphodiesterase and relaxation of rabbit ileum.
    Berndt SF; Schulz HU
    J Neural Transm; 1974; Suppl 11(0):187-93. PubMed ID: 4370809
    [No Abstract]   [Full Text] [Related]  

  • 8. Histochemical evidence of cyclic nucleotide phosphodiesterase in photoreceptor outer segments.
    Robb RM
    Invest Ophthalmol; 1974 Oct; 13(10):740-7. PubMed ID: 4370068
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 3,7-dimethyl-1-(5-oxo-hexyl)xanthine and 1-hexyl-3,7-dimethyl xanthine on cyclic AMP phosphodiesterase of the human umbilical cord vessels.
    Stefanovich V
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):655-62. PubMed ID: 4349608
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium and papaverine interaction with soluble cardiac phosphodiesterase.
    Carpenedo F; Gaion RM; Fassina G
    Biochem Pharmacol; 1975 Nov; 24(22):2069-73. PubMed ID: 174573
    [No Abstract]   [Full Text] [Related]  

  • 11. The action of chlorpromazine on the metabolism of cyclic adenosine 3',5'-monophosphate.
    Wollemann M
    Adv Biochem Psychopharmacol; 1974; 9(0):731-8. PubMed ID: 4151772
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of platelet aggregation by isochinoline derivatives.
    Markwardt F
    Acta Univ Carol Med Monogr; 1972; 52():79-82. PubMed ID: 4361263
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action mechanism of vascular spasmolytics. 5. Drug-related relaxation and adenosine-3',5'-monophosphate content of isolated coronary arteries under conditions of fluoride-induced contracture].
    Fermum R; Möritz KU
    Acta Biol Med Ger; 1979; 38(8):1211-23. PubMed ID: 231362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic adenosine 3',5'-monophosphate in guinea pig cerebral cortical slices. II. The role of phosphodiesterase activity in the regulation of levels of cyclic adenosine 3',5'-monophosphate.
    Schultz J; Daly JW
    J Biol Chem; 1973 Feb; 248(3):853-9. PubMed ID: 4405428
    [No Abstract]   [Full Text] [Related]  

  • 15. The action of vasodilating drugs on isolated basilar, coronary and mesenteric arteries of the dog.
    Toda N
    J Pharmacol Exp Ther; 1974 Oct; 191(1):139-46. PubMed ID: 4417567
    [No Abstract]   [Full Text] [Related]  

  • 16. Assay of phosphodiesterase with radioactively labeled cyclic 3',5'-AMP as substrate.
    Pöch G
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(3):272-99. PubMed ID: 4337726
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of 3',5'-cyclic AMP phosphodiesterase with anti-inflammatory agents.
    Stefanovich V
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):573-82. PubMed ID: 4363357
    [No Abstract]   [Full Text] [Related]  

  • 18. High-pressure anion exchange chromatography and enzymatic isotope displacement assays for cyclic AMP and cyclic GMP.
    Brooker G
    Adv Cyclic Nucleotide Res; 1972; 2():111-29. PubMed ID: 4352292
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adenosine-3',5'-monophosphate content and muscle tension in isolated coronary arteries under the effect of lanthanum ions].
    Fermum R; Möritz KU; Schäfer U; Leibelt M
    Biomed Biochim Acta; 1984; 43(11):1285-94. PubMed ID: 6085268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP as a mediator of the relaxing action of papaverine, nitroglycerine, diazoxide and hydralazine in intestinal and vascular smooth muscle.
    Andersson R
    Acta Pharmacol Toxicol (Copenh); 1973; 32(5):321-36. PubMed ID: 4354107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.